CYCLERION THERAPEUTICS, INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-43.2% -$781K
$1M
R&D↑+826.8% +$463K
$519K
D&A
—
Operating Income↑+10.8% +$122K
$-1M
EBITDA↑+10.8% +$122K
$-1M
Tax Provision
$0
Net Income↓-35.0% -$253K
$-976K
Operating Margin↑+466.5pts
-115.0%
Net Margin↑+261.1pts
-111.5%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR Foreign Differential (pp)↑+0.0pts
0.0%
Operating Lease Cost
$0
Revenue YoY Variation
-43.2%
Income YoY Variation↓-70.4pts
10.8%
Revenue QoQ Variation↓-813.8pts
17.1%
Income QoQ Variation↑+21.3pts
39.8%